Medicare Enrolled
Dr. Daniel Frank, M.D.
Internal Medicine · Lisle, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Frank from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frank?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Frank
Dr. Daniel Frank is an internal medicine specialist in Lisle, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Frank performed 207,733 Medicare services across 5,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Frank received a total of $1,757 from 30 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Frank is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in IL
$1,757 industry payments
Medicare Practice Summary
Medicare Utilization ↗207,733
Medicare services
Top 0% in IL for internal medicine
5,832
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10,387 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
28,100 | $2 | $12 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
28,050 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 26,600 | $43 | $82 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
20,700 | $0 | $3 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
19,800 | $38 | $132 |
| Denosumab injection (Prolia/Xgeva) | 15,900 | $18 | $27 |
| Paclitaxel chemotherapy injection | 12,318 | $0 | $5 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
10,200 | $15 | $29 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,825 | $34 | $81 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,500 | $0 | $1 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,400 | $26 | $149 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,648 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,263 | $8 | $20 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,250 | $20 | $169 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,959 | $8 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,701 | $10 | $55 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,390 | $1 | $142 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
1,356 | $109 | $740 |
| Anti-nausea injection (ondansetron/Zofran) | 912 | $0 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
764 | $99 | $229 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $64 | $157 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
722 | $13 | $54 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
667 | $107 | $380 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
520 | $2 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
514 | $11 | $62 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
504 | $50 | $201 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 475 | $3 | $100 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
396 | $2 | $50 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
389 | $6 | $30 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
351 | $6 | $416 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
274 | $23 | $95 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
260 | $60 | $202 |
| Injection, potassium chloride, per 2 meq | 230 | $0 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
219 | $24 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
215 | $127 | $359 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
211 | $13 | $70 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 210 | $133 | $2,001 |
| Iron level test | 207 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
207 | $9 | $45 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
186 | $1 | $3 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
173 | $4 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
172 | $6 | $33 |
| PSA test (prostate cancer screening) | 169 | $18 | $94 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
156 | $2 | $23 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
146 | $54 | $189 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
137 | $7 | $34 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
137 | $27 | $156 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
120 | $5 | $25 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
112 | $1 | $3 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
103 | $3 | $14 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
99 | $16 | $70 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
98 | $26 | $95 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
84 | $19 | $97 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
69 | $1 | $10 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
65 | $20 | $67 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
63 | $46 | $167 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
62 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
60 | $14 | $77 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
59 | $4 | $21 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
52 | $5 | $26 |
| Cardiolipin antibody (tissue antibody) measurement | 48 | $25 | $131 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
46 | $214 | $785 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 45 | $25 | $131 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $15 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $11 | $45 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
36 | $12 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $148 | $307 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $101 | $295 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
26 | $16 | $86 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
26 | $4 | $20 |
| New patient office visit, complex (60-74 min) | 26 | $175 | $443 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $65 | $151 |
| Coagulation function measurement, d-dimer; quantitative | 16 | $10 | $52 |
| HIV-1 antigen and HIV-1/2 antibody test A laboratory test using immunoassay techniques to detect HIV-1 antigens and antibodies for both HIV-1 and HIV-2. |
15 | $24 | $280 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $132 | $431 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $146 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.2% high complexity
68.7% medium
5.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,757
Total received (2018-2024)
Avg $251/year across 7 years
Top 24% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
82
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,704 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$226
2023
$534
2022
$571
2021
$180
2020
$16
2019
$107
2018
$124
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$53
Gilead Sciences, Inc.
$48
Novartis Pharmaceuticals Corporation
$40
Genentech USA, Inc.
$30
Daiichi Sankyo Inc.
$27
E.R. Squibb & Sons, L.L.C.
$14
Celgene Corporation
$13
Top 3 companies account for 62.8% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$354
Novartis Pharmaceuticals Corporation
$179
Gilead Sciences, Inc.
$172
Amgen Inc.
$81
Merck Sharp & Dohme Corporation
$80
PFIZER INC.
$80
Lilly USA, LLC
$61
Celgene Corporation
$60
Myriad Genetic Laboratories, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$46
EMD Serono, Inc.
$44
G1 Therapeutics, Inc.
$43
Seagen Inc.
$43
CTI BioPharma Corp.
$43
Janssen Biotech, Inc.
$41
Janssen Scientific Affairs, LLC
$38
Merck Sharp & Dohme LLC
$37
Exelixis Inc.
$31
E.R. Squibb & Sons, L.L.C.
$30
GlaxoSmithKline, LLC.
$27
Daiichi Sankyo Inc.
$27
Pharmacyclics LLC, an AbbVie Company
$26
Puma Biotechnology, Inc.
$26
Alnylam Pharmaceuticals Inc.
$22
Coherus Biosciences Inc.
$22
Karyopharm Therapeutics Inc.
$21
GENZYME CORPORATION
$19
ARRAY BIOPHARMA INC
$17
Blueprint Medicines Corporation
$16
ABBVIE INC.
$13
Top 3 companies account for 40.1% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · Avastin · BAVENCIO · BOSULIF · BRAFTOVI · COSELA · Cabometyx · DARZALEX · ERLEADA · Enhertu · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · JEVTANA · KEYTRUDA · Kadcyla · Lunsumio · MEKINIST · MYRISK · Nerlynx · Nplate · OPDIVO · PROMACTA · Pomalyst · RETEVMO · SCEMBLIX · TABRECTA · TECENTRIQ · TUKYSA · Trodelvy · Udenyca · VENCLEXTA · Vectibix · Vonjo · XALKORI · XPOVIO · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
5,002
Per 100K population
539.4
County median income
$110,502
Nearest hospital
ADVOCATE GOOD SAMARITAN HOSPITAL
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Frank is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Frank experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Frank performed 28,100 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frank receive payments from pharmaceutical companies?
Yes. Dr. Frank received a total of $1,757 from 30 companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frank's costs compare to other internal medicine physicians in Lisle?
Dr. Frank's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frank) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lisle
Browse internal medicine physicians in Lisle ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology